About Astellas Venture Management
Astellas Venture Management is a venture capital firm founded in 2005. It is primarily based out of Brisbane, United States. As of Apr 2025, Astellas Venture Management is an active investor, having invested in 61 companies, with 1 new investment in the last 12 months. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and HealthTech. Most recently it led the $4.8M Seed round of Somite along with Montage Ventures.
Overall, Astellas Venture Management portfolio has seen 11 IPOs and 15 acquisitions including key companies like TScan Therapeutics, Verastem and Epizyme. A lot of funds co-invest with Astellas Venture Management, with names like sharing a substantial percentage of its portfolio.
Astellas Venture Management has team of 7 people including 1 partners.
Key Metrics
Team Members
, &
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series B &
Portfolio IPOs
Portfolio Acquisitions
Portfolio Soonicorns
Deals in last 12 months
Astellas Venture Management's Year-on-Year Investment Trends
Astellas Venture Management has invested in 61 companies over the last 20 years, with an average of 2 new investments annually in the last 10 years. In 2024, it made 3 investments, while as of Apr 2025, it has made 1 investment in this year. Its most recent first time investment was in Somite and most recent follow-on round was in Solu Therapeutics.
Year | No. of Investments | ||
---|---|---|---|
1stÌý¸é´Ç³Ü²Ô»å | Follow-on | Total | |
2025 (YTD) | 0 | 1 | 1 |
2024 | 1 | 2 | 3 |
2023 | 2 | 2 | 4 |
2022 | 4 | 0 | 4 |
2021 | 4 | 0 | 4 |
2020 | 4 | 0 | 4 |
2019 | 1 | 3 | 4 |
2018 | 4 | 0 | 4 |
2017 | 0 | 1 | 1 |
2016 | 2 | 3 | 5 |

Get Astellas Venture Management's portfolio delivered to your inbox!
Astellas Venture Management's Investment Trends by Stage
Astellas Venture Management has made 20 investments in Series A stage with an average round size of $35.4M, 13 investments in Series B stage with an average round size of $33.6M and 5 investments in Seed stage with an average round size of $45.3M.Note: We have considered here, only first round of investments
Stage of entry | No. of Investments |
---|---|
Series A | 20 |
Series B | 13 |
Seed | 5 |
Series C | 2 |
PE | 1 |
Others | 1 |
Astellas Venture Management's Investment Trends by Sector
Astellas Venture Management has a diverse portfolio, with companies operating in the Life Sciences, High Tech, Sustainability Tech, HealthTech and Healthcare. Notably, it has invested in 53 Tech companies, 40 Enterprise (B2B) companies, 1 Artificial intelligence company and at least 1 company focusing on Social impact.
Note: We have considered here, only first round of investments
Sector | No. of Investments |
---|---|
Life Sciences | 38 |
High Tech | 10 |
Sustainability Tech | 3 |
HealthTech | 2 |
Healthcare | 2 |
Others | 5 |
Astellas Venture Management's Investment Trends by Geography
Astellas Venture Management has made most investments in United States (47), followed by United Kingdom where it has made 8 investments.
Note: We have considered here, only first round of investments
Country | No. of Investments |
---|---|
United States | 31 |
United Kingdom | 7 |
Japan | 2 |
Canada | 1 |
Switzerland | 1 |
Astellas Venture Management's recent investments
Here are the most recent investments by Astellas Venture Management:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
---|---|---|---|---|---|
Apr 09, 2025 | United States | Series A | $41M | [+8] | |
Sep 10, 2024 | United Kingdom | Series B | $12M | Parkwalk [+3] | |
Sep 03, 2024 | United States | Seed | $4.8M | ||
Feb 01, 2024 | United Kingdom | Series B | $12.2M | ||
Dec 12, 2023 | United States | Series A | $60M | [+7] |
IPOs and Publicly Listed companies in Astellas Venture Management's Portfolio
Here are Astellas Venture Management's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
---|---|---|---|---|
Jul 30, 2024 | Nov 22, 2019 | Series B | $25.8M | |
Jul 16, 2021 | Jan 09, 2020 | Series B | $35M | |
Oct 02, 2020 | Sep 21, 2018 | Series A | $61.3M | |
May 23, 2019 | Dec 10, 2012 | Series A | $6.02M | |
Oct 23, 2018 | Jun 15, 2012 | Series B | $48.5M |